Bessemer Group
MIRM icon

Bessemer Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Bessemer Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2K Hold
29
– – ﹤0.01% 2416
2026
Q2 		$3K Buy
+29
New +$2.91K ﹤0.01% 2354
2026
Q1 		– Sell
-2
Closed – – 2620
2025
Q4 		$0 Hold
2
– – ﹤0.01% 2642
2025
Q3 		$0 Buy
+2
New +$127 ﹤0.01% 2625
2024
Q4 		– Sell
-30
Closed -$1K – 2593
2024
Q3 		$1K Buy
+30
New +$1.2K ﹤0.01% 2472

Other funds holding MIRM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Bessemer Group's MIRM Position: Q3 2026 in Review

Bessemer Group held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2026 at 29 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

Bessemer Group first reported a position in MIRM in Q3 2024 and has held it in 5 quarters since. The position peaked at $3K in Q2 2026. 147 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Bessemer Group held 29 shares of Mirum Pharmaceuticals worth $2K as of Q3 2026.
  • Bessemer Group left its Mirum Pharmaceuticals share count unchanged in Q3 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #2416 holding.
  • Bessemer Group first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Bessemer Group's Mirum Pharmaceuticals position peaked at $3K in Q2 2026.
  • 147 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.